CATALYST CAPITAL ADVISORS LLC – AbbVie Inc. Transaction History
CATALYST CAPITAL ADVISORS LLC portfolio value:
$173,000
portfolio value
CATALYST CAPITAL ADVISORS LLC quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -25K | $134.21 | 1.29K | |
| Q2 2022 | share | Decrease | -31.38% | -590 shares | -107K | $153.16 | 1.29K |
| Q1 2022 | share | Increase | +7.80% | 136 shares | 69K | $162.11 | 1.88K |
| Q4 2021 | share | Increase | +35.19% | 454 shares | 97K | $135.93 | 1.74K |
| Q3 2021 | share | Decrease | -96.60% | -36.6K shares | -4.12M | $106.6 | 1.29K |
| Q2 2021 | share | Decrease | -0.81% | -310 shares | 134K | $110.09 | 37.89K |
| Q1 2021 | share | Decrease | -6.83% | -2.8K shares | -259K | $104.49 | 38.2K |
| Q4 2020 | share | Increase | 0.00% | 41K shares | 4.39M | $102.27 | 41K |
| Q1 2019 | share | Decrease | -100.00% | -1.9K shares | -175K | $69.89 | 0 |
| Q4 2018 | share | Decrease | -31.11% | -858 shares | -86K | $78.96 | 1.9K |
| Q3 2018 | share | Increase | +4.35% | 115 shares | 16K | $80.16 | 2.75K |
| Q2 2018 | share | Increase | +7.13% | 176 shares | 11K | $77.74 | 2.64K |
| Q1 2018 | share | Decrease | -23.55% | -760 shares | -78K | $78.6 | 2.46K |
| Q4 2017 | share | Decrease | -17.83% | -700 shares | -37K | $79.74 | 3.22K |
| Q3 2017 | share | 0.00% | 0 shares | 64K | $72.76 | 3.92K | |
| Q2 2017 | share | Decrease | -7.27% | -308 shares | 9K | $58.85 | 3.92K |
| Q1 2017 | share | Decrease | -92.57% | -52.75K shares | -3.29M | $52.36 | 4.23K |
| Q4 2016 | share | Decrease | -16.23% | -11.04K shares | -722K | $49.8 | 56.99K |
| Q3 2016 | share | Increase | +384.90% | 54.00K shares | 3.42M | $49.69 | 68.03K |
| Q2 2016 | share | 0.00% | 0 shares | 68K | $48.35 | 14.03K | |
| Q1 2016 | share | Increase | +6.05% | 800 shares | 17K | $44.19 | 14.03K |